(Q37797922)

23 August 2017

title

Alzheimer's disease: the strength of association of costs with different measures of disease severity (English)

1 reference

23 August 2017

0 references

Mauskopf J

1

1 reference

23 August 2017

Racketa J

series ordinal

2

1 reference

23 August 2017

Sherrill E

series ordinal

3

1 reference

23 August 2017

publication date

1 October 2010

1 reference

The Journal of Nutrition, Health and Aging

23 August 2017

published in

1 reference

23 August 2017

volume

14

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

655-663

1 reference

https://scigraph.springernature.com/pub.10.1007/s12603-010-0312-6

23 August 2017

exact match

0 references

cites work

Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0312-6

Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0312-6

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0312-6

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0312-6

Informal Costs of Dementia Care: Estimates From the National Longitudinal Caregiver Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0312-6

The relative effect of Alzheimer's disease and related dementias, disability, and comorbidities on cost of care for elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-010-0312-6

Relation between severity of Alzheimer's disease and costs of caring

21 January 2018

1 reference

12 December 2020

Economic cost of dementia patients according to the limitation of the activities of daily living in Korea

1 reference

12 December 2020

Measurement of informal care time in a study of patients with dementia.

1 reference

12 December 2020

Cost of dementia: impact of disease progression estimated in longitudinal data.

1 reference

12 December 2020

Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands

1 reference

12 December 2020

A dependency model for patients with Alzheimer's disease: its validation and relationship to the costs of care--the LASER-AD Study

1 reference

12 December 2020

National estimates of the quantity and cost of informal caregiving for the elderly with dementia

1 reference

12 December 2020

Economic impact of Alzheimer's disease in the United Kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease.

1 reference

12 December 2020

Costs and cognitive disability: modelling the underlying associations.

1 reference

12 December 2020

The cost of Alzheimer's disease in managed care: a cross-sectional study

1 reference

12 December 2020

The economic burden of Alzheimer's disease care

1 reference

12 December 2020

Costs of Mini Mental State Examination-related cognitive impairment.

1 reference

12 December 2020

Patients with Alzheimer's disease living at home in France: costs and consequences of the disease

1 reference

12 December 2020

The impact of symptom severity on the cost of Alzheimer's disease.

1 reference

12 December 2020

Cost effectiveness of memantine in Alzheimer's disease: an analysis based on a probabilistic Markov model from a UK perspective

1 reference

12 December 2020

Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias.

1 reference

12 December 2020

Economic considerations in the management of Alzheimer's disease

1 reference

12 December 2020

Time use and costs of institutionalised elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen Project--a population based study in Sweden

1 reference

12 December 2020

Cholinesterase inhibitors for Alzheimer's disease

1 reference

12 December 2020

Donepezil for the Treatment of Mild to Moderate Alzheimer’s Disease in France: The Economic Implications

1 reference

12 December 2020

Patient dependence and longitudinal changes in costs of care in Alzheimer's disease

1 reference

12 December 2020

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease

1 reference

12 December 2020

[Cost relation between severity of Alzheimer's disease and cognitive and functional impairment]

1 reference

12 December 2020

Clinical predictors of the indirect costs of Alzheimer disease.

1 reference

12 December 2020

Progress in clinical neurosciences: cognitive markers of progression in Alzheimer's disease.

1 reference

12 December 2020

Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study

1 reference

12 December 2020

The cost of dementia in Denmark: the Odense Study

1 reference

12 December 2020

The incremental direct costs associated with behavioral symptoms in AD.

1 reference

12 December 2020

Determinants of costs of care for patients with Alzheimer's disease

1 reference

12 December 2020

Estimating long-term cost savings from treatment of Alzheimer's disease. A modelling approach

1 reference

12 December 2020

Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil.

1 reference

12 December 2020

Family history of dementia does not influence the progression of Alzheimer's disease at two years: results from the REAL.FR Study.

1 reference

12 December 2020

Cost effectiveness of memantine in moderately severe to severe Alzheimer's disease : a markov model in Finland

1 reference

12 December 2020

Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.

1 reference

12 December 2020

The contribution of neuropsychiatric symptoms to the cost of dementia care

1 reference

12 December 2020

Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease

1 reference

12 December 2020

Cognitive disability and direct care costs for elderly people.

1 reference

12 December 2020

Time spent on informal and formal care giving for persons with dementia in Sweden.

1 reference

12 December 2020

[Costs of health care resources of ambulatory-care patients diagnosed with Alzheimer's disease in Spain]

1 reference

12 December 2020

Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis

1 reference

12 December 2020

Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine

1 reference

12 December 2020

Estimating the relationship between disease progression and cost of care in dementia

1 reference

12 December 2020

The cost of dementia in Europe: a review of the evidence, and methodological considerations

1 reference

12 December 2020

10.1007/S12603-010-0312-6

Identifiers

DOI

1 reference

23 August 2017

1 reference